Unknown

Dataset Information

0

Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.


ABSTRACT: Dendritic cells (DCs) are professional antigen (Ag)-presenting cells capable of inducing immune responses to tumor Ags and, therefore, play a central role in the induction of antitumor immunity. There is a large amount of evidence, however, about paucity of tumor-associated DCs and that DCs' immunogenic functions are suppressed in a tumor environment. Here we describe a potent in situ vaccine targeting tumoral DCs in vivo. This vaccine comprised of an oncolytic adenovirus expressing RANTES (regulated upon activation, normally T expressed, and presumably secreted) (Ad-RANTES-E1A), enhanced tumor infiltration, and maturation of Ag-presenting cells in vivo. In this study, we show that intratumoral vaccinations with Ad-RANTES-E1A induced significant primary tumor growth regression and blocked metastasis formation in JC and E.G-7 murine tumor models. This vaccine recruited DCs, macrophages, natural killer cells, and CD8+ T cells to the tumor site, and thus enhanced Ag-specific cytotoxic T lymphocyte responses and natural killer cell responses. DCs purified from the Ad-RANTES-E1A-treated E.G-7 tumors secreted significantly higher levels of interferon-gamma and interleukin-12, as compared with control groups and more efficiently enhanced CD8+ T-cell response. This in situ immunization strategy could be a potent antitumor immunotherapy approach for aggressive established tumors.

SUBMITTER: Lapteva N 

PROVIDER: S-EPMC4146345 | biostudies-literature | 2009 Feb-Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.

Lapteva Natalia N   Aldrich Melissa M   Weksberg David D   Rollins Lisa L   Goltsova Tatiana T   Chen Si-Yi SY   Huang Xue F XF  

Journal of immunotherapy (Hagerstown, Md. : 1997) 20090201 2


Dendritic cells (DCs) are professional antigen (Ag)-presenting cells capable of inducing immune responses to tumor Ags and, therefore, play a central role in the induction of antitumor immunity. There is a large amount of evidence, however, about paucity of tumor-associated DCs and that DCs' immunogenic functions are suppressed in a tumor environment. Here we describe a potent in situ vaccine targeting tumoral DCs in vivo. This vaccine comprised of an oncolytic adenovirus expressing RANTES (regu  ...[more]

Similar Datasets

| S-EPMC4839379 | biostudies-literature
| S-EPMC2835257 | biostudies-literature
| S-EPMC6171074 | biostudies-literature
| S-EPMC3701076 | biostudies-literature
| S-EPMC7851489 | biostudies-literature
| S-EPMC6858551 | biostudies-literature
| S-EPMC5048764 | biostudies-literature
| S-EPMC10126305 | biostudies-literature
| S-EPMC7704751 | biostudies-literature
2022-12-09 | GSE206634 | GEO